Metformin inhibits STAT3 and MAPK signaling through AMPK activation in CSF3RT618I cells (2022)
- Authors:
- USP affiliated authors: REGO, EDUARDO MAGALHÃES - FM ; MACHADO NETO, JOÃO AGOSTINHO - ICB ; TRAINA, FABÍOLA - FMRP ; FONSECA, NATASHA PEIXOTO - FMRP ; FENERICH, BRUNA ALVES - FMRP ; MARTINS, DIEGO ANTONIO PEREIRA - FMRP ; SILVA, ANTONIO BRUNO ALVES DA - FMRP
- Unidades: FM; ICB; FMRP
- DOI: 10.1182/blood-2022-167392
- Subjects: METFORMINA; LEUCEMIA; MARCADOR MOLECULAR
- Language: Inglês
- Imprenta:
- Source:
- Conference titles: ASH Annual Meeting and Exposition
- Status:
- Nenhuma versão em acesso aberto identificada
-
ABNT
FONSECA, Natasha Peixoto et al. Metformin inhibits STAT3 and MAPK signaling through AMPK activation in CSF3RT618I cells. Blood. Amsterdam: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1182/blood-2022-167392. Acesso em: 17 mar. 2026. , 2022 -
APA
Fonseca, N. P., Fenerich, B. A., Pereira-Martins, D. A., Garibaldi, P. M. M., Coelho-Silva, J. L., Silva, A. B. A., et al. (2022). Metformin inhibits STAT3 and MAPK signaling through AMPK activation in CSF3RT618I cells. Blood. Amsterdam: Faculdade de Medicina, Universidade de São Paulo. doi:10.1182/blood-2022-167392 -
NLM
Fonseca NP, Fenerich BA, Pereira-Martins DA, Garibaldi PMM, Coelho-Silva JL, Silva ABA, Fernandes JC, Silva CLA, Rego EM, Machado Neto JA, Traina F. Metformin inhibits STAT3 and MAPK signaling through AMPK activation in CSF3RT618I cells [Internet]. Blood. 2022 ; 140( suppl. 1): 12153-12154.[citado 2026 mar. 17 ] Available from: https://doi.org/10.1182/blood-2022-167392 -
Vancouver
Fonseca NP, Fenerich BA, Pereira-Martins DA, Garibaldi PMM, Coelho-Silva JL, Silva ABA, Fernandes JC, Silva CLA, Rego EM, Machado Neto JA, Traina F. Metformin inhibits STAT3 and MAPK signaling through AMPK activation in CSF3RT618I cells [Internet]. Blood. 2022 ; 140( suppl. 1): 12153-12154.[citado 2026 mar. 17 ] Available from: https://doi.org/10.1182/blood-2022-167392 - Phenformin increases early hematopoietic progenitors in the Jak2V617F murine model
- Irs1S57X heterozygous mutant mice display normal hematopoiesis and phenotypic features, while homozygous knockout exhibit high fetal or postnatal lethality
- Differential cytotoxic activity of pharmacological inhibitors of IGF1R-related pathways in JAK2V617F driven cells
- Differential cytotoxic activity of pharmacological inhibitors of IGF1R-related pathways in JAK2(V617F) driven cells
- Metformin reduces tumor burden and splenomegaly in JAK2V617F murine models
- Stathmin 1 is highly expressed in acute promyelocytic leukemia and microtubule dynamics is a potential target for ATRA-resistant APL cells
- Padronização de modelo xenográfico sistêmico de leucemia linfoide aguda
- The pharmacological IGF1R-IRS1/2 inhibitor NT157 presents multiple anti-neoplastic effects in myeloproliferative neoplasms
- Stathmin 1 is highly expressed and is inhibited by paclitaxel in acute lymphoblastic leukemia cells
- Stathmin 1 é altamente expressa em leucemia promielocítica aguda e a dinâmica dos microtúbulos é um alvo potencial para células PML-RAR resistentes ao atra
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
003268640.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
